Desloratadine - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509242571

Publication Date:

September 27, 2024

Pages:

128

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis.
The global market for Desloratadine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Desloratadine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Desloratadine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Desloratadine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Desloratadine include Vasudha Pharma, Divis Labs, Sun Pharma, Lupin, Mylan, Cadila Pharma, Dr. Reddy's, Cipla and Orchid Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Desloratadine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Desloratadine by region & country, by Type, and by Application.
The Desloratadine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desloratadine.
麻豆原创 Segmentation
By Company
Vasudha Pharma
Divis Labs
Sun Pharma
Lupin
Mylan
Cadila Pharma
Dr. Reddy's
Cipla
Orchid Pharma
Tapi Teva
Farmhispania
Hainan Poly Pharm
Suanfarma
Segment by Type:
笔耻谤颈迟测鈮�98%
笔耻谤颈迟测鈮�99%
Segment by Application
Desloratadine Oral Solution
Desloratadine Oral Tablet
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Desloratadine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Desloratadine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Desloratadine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Desloratadine Product Introduction
1.2 Global Desloratadine 麻豆原创 Size Forecast
1.2.1 Global Desloratadine Sales Value (2019-2030)
1.2.2 Global Desloratadine Sales Volume (2019-2030)
1.2.3 Global Desloratadine Sales Price (2019-2030)
1.3 Desloratadine 麻豆原创 Trends & Drivers
1.3.1 Desloratadine Industry Trends
1.3.2 Desloratadine 麻豆原创 Drivers & Opportunity
1.3.3 Desloratadine 麻豆原创 Challenges
1.3.4 Desloratadine 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Desloratadine Players Revenue Ranking (2023)
2.2 Global Desloratadine Revenue by Company (2019-2024)
2.3 Global Desloratadine Players Sales Volume Ranking (2023)
2.4 Global Desloratadine Sales Volume by Company Players (2019-2024)
2.5 Global Desloratadine Average Price by Company (2019-2024)
2.6 Key Manufacturers Desloratadine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Desloratadine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Desloratadine
2.9 Desloratadine 麻豆原创 Competitive Analysis
2.9.1 Desloratadine 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Desloratadine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Desloratadine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 笔耻谤颈迟测鈮�98%
3.1.2 笔耻谤颈迟测鈮�99%
3.2 Global Desloratadine Sales Value by Type
3.2.1 Global Desloratadine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Desloratadine Sales Value, by Type (2019-2030)
3.2.3 Global Desloratadine Sales Value, by Type (%) (2019-2030)
3.3 Global Desloratadine Sales Volume by Type
3.3.1 Global Desloratadine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Desloratadine Sales Volume, by Type (2019-2030)
3.3.3 Global Desloratadine Sales Volume, by Type (%) (2019-2030)
3.4 Global Desloratadine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Desloratadine Oral Solution
4.1.2 Desloratadine Oral Tablet
4.2 Global Desloratadine Sales Value by Application
4.2.1 Global Desloratadine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Desloratadine Sales Value, by Application (2019-2030)
4.2.3 Global Desloratadine Sales Value, by Application (%) (2019-2030)
4.3 Global Desloratadine Sales Volume by Application
4.3.1 Global Desloratadine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Desloratadine Sales Volume, by Application (2019-2030)
4.3.3 Global Desloratadine Sales Volume, by Application (%) (2019-2030)
4.4 Global Desloratadine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Desloratadine Sales Value by Region
5.1.1 Global Desloratadine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Desloratadine Sales Value by Region (2019-2024)
5.1.3 Global Desloratadine Sales Value by Region (2025-2030)
5.1.4 Global Desloratadine Sales Value by Region (%), (2019-2030)
5.2 Global Desloratadine Sales Volume by Region
5.2.1 Global Desloratadine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Desloratadine Sales Volume by Region (2019-2024)
5.2.3 Global Desloratadine Sales Volume by Region (2025-2030)
5.2.4 Global Desloratadine Sales Volume by Region (%), (2019-2030)
5.3 Global Desloratadine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Desloratadine Sales Value, 2019-2030
5.4.2 North America Desloratadine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Desloratadine Sales Value, 2019-2030
5.5.2 Europe Desloratadine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Desloratadine Sales Value, 2019-2030
5.6.2 Asia Pacific Desloratadine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Desloratadine Sales Value, 2019-2030
5.7.2 South America Desloratadine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Desloratadine Sales Value, 2019-2030
5.8.2 Middle East & Africa Desloratadine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Desloratadine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Desloratadine Sales Value
6.2.1 Key Countries/Regions Desloratadine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Desloratadine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Desloratadine Sales Value, 2019-2030
6.3.2 United States Desloratadine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Desloratadine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Desloratadine Sales Value, 2019-2030
6.4.2 Europe Desloratadine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Desloratadine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Desloratadine Sales Value, 2019-2030
6.5.2 China Desloratadine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Desloratadine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Desloratadine Sales Value, 2019-2030
6.6.2 Japan Desloratadine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Desloratadine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Desloratadine Sales Value, 2019-2030
6.7.2 South Korea Desloratadine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Desloratadine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Desloratadine Sales Value, 2019-2030
6.8.2 Southeast Asia Desloratadine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Desloratadine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Desloratadine Sales Value, 2019-2030
6.9.2 India Desloratadine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Desloratadine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Vasudha Pharma
7.1.1 Vasudha Pharma Company Information
7.1.2 Vasudha Pharma Introduction and Business Overview
7.1.3 Vasudha Pharma Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Vasudha Pharma Desloratadine Product Offerings
7.1.5 Vasudha Pharma Recent Development
7.2 Divis Labs
7.2.1 Divis Labs Company Information
7.2.2 Divis Labs Introduction and Business Overview
7.2.3 Divis Labs Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Divis Labs Desloratadine Product Offerings
7.2.5 Divis Labs Recent Development
7.3 Sun Pharma
7.3.1 Sun Pharma Company Information
7.3.2 Sun Pharma Introduction and Business Overview
7.3.3 Sun Pharma Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sun Pharma Desloratadine Product Offerings
7.3.5 Sun Pharma Recent Development
7.4 Lupin
7.4.1 Lupin Company Information
7.4.2 Lupin Introduction and Business Overview
7.4.3 Lupin Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Lupin Desloratadine Product Offerings
7.4.5 Lupin Recent Development
7.5 Mylan
7.5.1 Mylan Company Information
7.5.2 Mylan Introduction and Business Overview
7.5.3 Mylan Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mylan Desloratadine Product Offerings
7.5.5 Mylan Recent Development
7.6 Cadila Pharma
7.6.1 Cadila Pharma Company Information
7.6.2 Cadila Pharma Introduction and Business Overview
7.6.3 Cadila Pharma Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Cadila Pharma Desloratadine Product Offerings
7.6.5 Cadila Pharma Recent Development
7.7 Dr. Reddy's
7.7.1 Dr. Reddy's Company Information
7.7.2 Dr. Reddy's Introduction and Business Overview
7.7.3 Dr. Reddy's Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Dr. Reddy's Desloratadine Product Offerings
7.7.5 Dr. Reddy's Recent Development
7.8 Cipla
7.8.1 Cipla Company Information
7.8.2 Cipla Introduction and Business Overview
7.8.3 Cipla Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cipla Desloratadine Product Offerings
7.8.5 Cipla Recent Development
7.9 Orchid Pharma
7.9.1 Orchid Pharma Company Information
7.9.2 Orchid Pharma Introduction and Business Overview
7.9.3 Orchid Pharma Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Orchid Pharma Desloratadine Product Offerings
7.9.5 Orchid Pharma Recent Development
7.10 Tapi Teva
7.10.1 Tapi Teva Company Information
7.10.2 Tapi Teva Introduction and Business Overview
7.10.3 Tapi Teva Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Tapi Teva Desloratadine Product Offerings
7.10.5 Tapi Teva Recent Development
7.11 Farmhispania
7.11.1 Farmhispania Company Information
7.11.2 Farmhispania Introduction and Business Overview
7.11.3 Farmhispania Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Farmhispania Desloratadine Product Offerings
7.11.5 Farmhispania Recent Development
7.12 Hainan Poly Pharm
7.12.1 Hainan Poly Pharm Company Information
7.12.2 Hainan Poly Pharm Introduction and Business Overview
7.12.3 Hainan Poly Pharm Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Hainan Poly Pharm Desloratadine Product Offerings
7.12.5 Hainan Poly Pharm Recent Development
7.13 Suanfarma
7.13.1 Suanfarma Company Information
7.13.2 Suanfarma Introduction and Business Overview
7.13.3 Suanfarma Desloratadine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Suanfarma Desloratadine Product Offerings
7.13.5 Suanfarma Recent Development
8 Industry Chain Analysis
8.1 Desloratadine Industrial Chain
8.2 Desloratadine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Desloratadine Sales Model
8.5.2 Sales Channel
8.5.3 Desloratadine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Vasudha Pharma
Divis Labs
Sun Pharma
Lupin
Mylan
Cadila Pharma
Dr. Reddy's
Cipla
Orchid Pharma
Tapi Teva
Farmhispania
Hainan Poly Pharm
Suanfarma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.